Cargando…

Overcoming EGFR Resistance in Metastatic Colorectal Cancer Using Vitamin C: A Review

Targeted monoclonal antibody therapy against Epidermal Growth Factor Receptor (EGFR) is a leading treatment modality against metastatic colorectal cancer (mCRC). However, with the emergence of KRAS and BRAF mutations, resistance was inevitable. Cells harboring these mutations overexpress Glucose Tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machmouchi, Ahmad, Chehade, Laudy, Temraz, Sally, Shamseddine, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045351/ https://www.ncbi.nlm.nih.gov/pubmed/36979659 http://dx.doi.org/10.3390/biomedicines11030678

Ejemplares similares

Potential Targets for Colorectal Cancer Prevention
por: Temraz, Sally, et al.
Publicado: (2013)

The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
por: Bouferraa, Youssef, et al.
Publicado: (2021)

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
por: Temraz, Sally, et al.
Publicado: (2015)

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
por: Mukherji, Deborah, et al.
Publicado: (2014)

Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions
por: Kreidieh, Malek, et al.
Publicado: (2020)

Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study
por: Temraz, Sally, et al.
Publicado: (2023)

A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
por: Temraz, Sally, et al.
Publicado: (2022)

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
por: Temraz, Sally, et al.
Publicado: (2019)

Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer
por: Baassiri, Amro, et al.
Publicado: (2020)

Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients
por: Nasr, Rihab, et al.
Publicado: (2018)

Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005–2008
por: Temraz, Sally, et al.
Publicado: (2017)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Breast Cancer in Low- and Middle-Income Countries: An Emerging and Challenging Epidemic
por: Tfayli, Arafat, et al.
Publicado: (2010)

Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018
por: Shamseddine, Ali, et al.
Publicado: (2014)

Overview in Breast Cancer Screening in Lebanon
por: Sbaity, Eman, et al.
Publicado: (2021)

Sunitinib Induced Thrombotic Thrombocytopenic Purpura in addition to Severe Hypothyroidism: A Case Report and Review of the Literature
por: El Dika, Imane, et al.
Publicado: (2014)

The Crosstalk between Microbiome and Immune Response in Gastric Cancer
por: Nasr, Rihab, et al.
Publicado: (2020)

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
por: Yang, Lu, et al.
Publicado: (2022)

COVID-19 vaccination immune response in patients with solid organ and haematologic malignancies: call for active monitoring
por: Chehade, Laudy, et al.
Publicado: (2021)

Oxidized Vitamin C (DHA) Overcomes Resistance to EGFR-targeted Therapy of Lung Cancer through Disturbing Energy Homeostasis
por: Ye, Mingtong, et al.
Publicado: (2019)

Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
por: Lorenzato, Annalisa, et al.
Publicado: (2020)

The unveiling of a new risk factor associated with bladder cancer in Lebanon
por: Temraz, Sally, et al.
Publicado: (2019)

The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study
por: Bouferraa, Youssef, et al.
Publicado: (2022)

Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
por: Knickelbein, Kyle, et al.
Publicado: (2018)

AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
por: Ye, Hua, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
por: Temraz, Sally, et al.
Publicado: (2021)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
por: Nassar, Farah J., et al.
Publicado: (2021)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

Exosomal microRNAs in colorectal cancer: Overcoming barriers of the metastatic cascade (Review)
por: Danac, Joshua Miguel C., et al.
Publicado: (2021)

Novel agents and strategies for overcoming EGFR TKIs resistance
por: Niu, Fei-Yu, et al.
Publicado: (2014)

Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
por: Kwon, Yoojung, et al.
Publicado: (2019)

Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors
por: Jia, Yong, et al.
Publicado: (2016)

Primary synovial sarcoma of the kidney: a case report of complete pathological response at a Lebanese tertiary care center
por: El Chediak, Alissar, et al.
Publicado: (2018)

Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
por: Li, Qing-Hai, et al.
Publicado: (2020)

Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
por: Zhou, Jing, et al.
Publicado: (2021)

The Ketogenic Diet in Colorectal Cancer: A Means to an End
por: Tamraz, Magie, et al.
Publicado: (2023)

EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells
por: Möller, Yvonne, et al.
Publicado: (2014)

Emerging strategies to overcome resistance to third-generation EGFR inhibitors
por: Shi, Kunyu, et al.
Publicado: (2022)

Proportion of cancer in a Middle eastern country attributable to established risk factors
por: Charafeddine, Maya A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mv8kdjjvt7av305vglcik6gcel